相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CRISPR/Cas9 DNA cleavage at SNP-derived PAM enables both in vitro and in vivo KRT12 mutation-specific targeting
D. G. Courtney et al.
GENE THERAPY (2016)
Rationally engineered Cas9 nucleases with improved specificity
Ian M. Slaymaker et al.
SCIENCE (2016)
The HTT CAG-Expansion Mutation Determines Age at Death but Not Disease Duration in Huntington Disease
Jae Whan Keum et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2016)
In Vivo CRISPR/Cas9 Gene Editing Corrects Retinal Dystrophy in the S334ter-3 Rat Model of Autosomal Dominant Retinitis Pigmentosa
Benjamin Bakondi et al.
MOLECULAR THERAPY (2016)
Sequence-Level Analysis of the Major European Huntington Disease Haplotype
Jong-Min Lee et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2015)
Identification of Genetic Factors that Modify Clinical Onset of Huntington's Disease
Jong-Min Lee et al.
CELL (2015)
HD iPSC-derived neural progenitors accumulate in culture and are susceptible to BDNF withdrawal due to glutamate toxicity
Virginia B. Mattis et al.
HUMAN MOLECULAR GENETICS (2015)
Efficient and Allele-Specific Genome Editing of Disease Loci in Human iPSCs
Cory Smith et al.
MOLECULAR THERAPY (2015)
Engineered CRISPR-Cas9 nucleases with altered PAM specificities
Benjamin P. Kleinstiver et al.
NATURE (2015)
Huntington disease
Gillian P. Bates et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Multi-kilobase homozygous targeted gene replacement in human induced pluripotent stem cells
Susan M. Byrne et al.
NUCLEIC ACIDS RESEARCH (2015)
Development and Applications of CRISPR-Cas9 for Genome Engineering
Patrick D. Hsu et al.
CELL (2014)
Allele-specific genome editing and correction of disease-associated phenotypes in rats using the CRISPR-Cas platform
K. Yoshimi et al.
NATURE COMMUNICATIONS (2014)
DNA targeting specificity of RNA-guided Cas9 nucleases
Patrick D. Hsu et al.
NATURE BIOTECHNOLOGY (2013)
Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease
Kirupa Sathasivam et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Common SNP-Based Haplotype Analysis of the 4p16.3 Huntington Disease Gene Region
Jong-Min Lee et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2012)
Single-Stranded RNAs Use RNAi to Potently and Allele-Selectively Inhibit Mutant Huntingtin Expression
Dongbo Yu et al.
CELL (2012)
Induced Pluripotent Stem Cells from Patients with Huntington's Disease Show CAG-Repeat-Expansion-Associated Phenotypes
CELL STEM CELL (2012)
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion
J. -M. Lee et al.
NEUROLOGY (2012)
Huntington's disease: from molecular pathogenesis to clinical treatment
Christopher A. Ross et al.
LANCET NEUROLOGY (2011)
Potent and Selective Antisense Oligonucleotides Targeting Single-Nucleotide Polymorphisms in the Huntington Disease Gene/Allele-Specific Silencing of Mutant Huntingtin
Jeffrey B. Carroll et al.
MOLECULAR THERAPY (2011)
CAG Expansion in the Huntington Disease Gene Is Associated with a Specific and Targetable Predisposing Haplogroup
Simon C. Warby et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2009)
Nonallele-specific Silencing of Mutant and Wild-type Huntingtin Demonstrates Therapeutic Efficacy in Huntington's Disease Mice
Ryan L. Boudreau et al.
MOLECULAR THERAPY (2009)
Induced pluripotent stem cell lines derived from human somatic cells
Junying Yu et al.
SCIENCE (2007)
Antisense oligonucleotide therapy for neurodegenerative disease
Richard A. Smith et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Cleavage pattern and emerging asymmetry of the mouse embryo
MZ Zernicka-Goetz
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice
I Dragatsis et al.
NATURE GENETICS (2000)
分享论文
